Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential
Jason J. Kwon(Dana-Farber Cancer Institute), Janaiah Kota(Ultragenyx Pharmaceutical (United States))
Cited by 72
Related Papers
Eteplirsen for the treatment of Duchenne muscular dystrophy
|Annals of Neurology|2013|793
Gentamicin‐induced readthrough of stop codons in duchenne muscular dystrophy
|Annals of Neurology|2010|272
Sustained alpha‐sarcoglycan gene expression after gene transfer in limb‐girdle muscular dystrophy, type 2D
|Annals of Neurology|2010|243
Limb‐girdle muscular dystrophy type 2D gene therapy restores α‐sarcoglycan and associated proteins
|Annals of Neurology|2009|214
Systematic profiling of conditional degron tag technologies for target validation studies
|Nature Communications|2022|48